Clinical trial
Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular…
NCT00100009 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00100009 |
|---|---|
| Title | Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration |
| Official title | Multi-Center, Randomized, Phase II/III Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide as an Adjunct to Photodynamic Therapy in Participants With Neovascular Age-Related Macular Degeneration |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | TAC-PF, Triamcinolone Acetonide |
| Enrollment | 30 |
| Start date | Dec 9, 2004 |
| Completion | Dec 20, 2006 |
| First posted | Dec 22, 2004 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: